The International Generic and Biosimilar medicines Association (IGBA) welcomes the adoption of the WHO Pandemic Agreement at the 78th World Health Assembly in May 2025. This landmark accord represents a critical step toward strengthening global preparedness and ensuring equitable access to essential health products in future pandemics.
The International Generic and Biosimilar medicines Association (IGBA) welcomes the adoption of the WHO Pandemic Agreement at the 78th World Health Assembly in May 2025. This landmark accord represents a critical step toward strengthening global preparedness and ensuring equitable access to essential health products in future pandemics.
